A randomized, lacebo-controlled trial of the dopamine-beta-hydroxylase (DBH) inhibitor

Ended Project Grant Awarded Last action

Award ID
W81XWH0910287
Recipient
Awarding agency
Obligated
$1,019,847

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Tuscaloosa, AL 35404, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment A randomized, placebo-controlled trial of the dopamine-beta-hydroxylase (DBH) inhibitor, nepicastat, for the treatment of ptsd in OIF/OEF veterans $0
Original award $1,019,847

Quick answers

Who received award W81XWH0910287?

W81XWH0910287 was awarded to Tuscaloosa Research And Education Advancement Corporation by Department of Defense on April 1, 2009.

How much is award W81XWH0910287 worth?

$1,019,847 has been obligated on W81XWH0910287.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award